RGD-modified PEG-PAMAM-DOX conjugates: In vitro and in vivo studies for glioma

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 79, Issue 2, 2011, Pages 232-240

  Zhang, Lihong ^a   Zhu, Saijie ^a   Qian, Lili ^a   Pei, Yuanying ^a   Qiu, Yongming ^b   Jiang, Yanyan ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; DENDRIMER; DOXORUBICIN; MACROGOL; POLYAMIDOAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG FORMULATION; DRUG TARGETING; GLIOMA; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; SURVIVAL TIME; SYNTHESIS; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

EID: 80054981542     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2011.03.025     Document Type: Article

References (29)

1. X. Ying, H. Wen, W.L. Lu, J. Du, J. Guo, W. Tian, Y. Men, Y. Zhang, R.J. Li, T.Y. Yang, D.W. Shang, J.N. Lou, L.R. Zhang, Q. Zhang, Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals, Journal of Controlled Release 141 (2010) 183-192.
2. W.M. Pardridge, BBB-genomics: creating new openings for brain-drug targeting, Drug Discovery Today 6 (2001) 381-383. (Pubitemid 32328285)
3. L.H. Treat, N. McDannold, N. Vykhodtseva, Y.Z. Zhang, K. Tam, K. Hynynen, Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound, International Journal of Cancer 121 (2007) 901-907. (Pubitemid 47106223)
4. K.A. Walter, R.J. Tamargo, A. Olivi, P.C. Burger, H. Brem, Intratumoral chemotherapy, Neurosurgery 37 (1995) 1128-1145.
5. H. Vonholst, E. Knochenhauer, H. Blomgren, V.P. Collins, L. Ehn, M. Lindquist, G. Noren, C. Peterson, Uptake of adriamycin in tumour and surrounding braintissue in patients with malignant gliomas, Acta Neurochirurgica 104 (1990) 13-16. (Pubitemid 20202089)
6. S.M. Moghimi, A.C. Hunter, J.C. Murray, Nanomedicine: current status and future prospects, Faseb Journal 19 (2005) 311-330. (Pubitemid 40316520)
7. I.J. Majoros, T.P. Thomas, C.B. Mehta, J.R. Baker, Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy, Journal of Medicinal Chemistry 48 (2005) 5892-5899. (Pubitemid 41324600)
8. A.K. Patri, A. Myc, J. Beals, T.P. Thomas, N.H. Bander, J.R. Baker, Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy, Bioconjugate Chemistry 15 (2004) 1174-1181. (Pubitemid 39552005)
9. C.L. Waite, C.M. Roth, PAMAM-RGD conjugates enhance siRNA delivery through a multicellular spheroid model of malignant glioma, Bioconjugate Chemistry 20 (2009) 1908-1916.
10. Q. Li, W. Xu, Novel anticancer targets and drug discovery in post genomic age, Current Medicinal Chemistry - Anti-Cancer Agents 5 (2005) 53-63. (Pubitemid 40081294)
11. X.B. Xiong, Y. Huang, W.L. Lu, X. Zhang, H. Zhang, T. Nagai, Q. Zhang, Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic, Journal of Controlled Release 107 (2005) 262-275. (Pubitemid 41316289)
12. Y.F. Zhang, J.C. Wang, D.Y. Bian, X. Zhang, Q. Zhang, Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies, European Journal of Pharmaceutics and Biopharmaceutics 74 (2010) 467-473.
13. W.C. Shen, H.J.P. Ryser, cis-Aconityl spacer between daunomycin and macromolecular carriers: a model of pH-sensitive linkage releasing drug from a lysosomotropic conjugate, Biochemical and Biophysical Research Communications 102 (1981) 1048-1054. (Pubitemid 12213826)
14. P. Chytil, T. Etrych, C. Konak, M. Sirova, T. Mrkvan, B. Rihova, K. Ulbrich, Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification, Journal of Controlled Release 115 (2006) 26-36. (Pubitemid 44415075)
15. A. Kakinoki, Y. Kaneo, Y. Ikeda, T. Tanaka, K. Fujita, Synthesis of poly(vinyl alcohol)-doxorubicin conjugates containing cis-aconityl acid-cleavable bond and its isomer dependent doxorubicin release, Biological and Pharmaceutical Bulletin 31 (2008) 103-110.
16. H.S. Yoo, E.A. Lee, T.G. Park, Doxorubicin-conjugated biodegradable polymeric micelles having acid-cleavable linkages, Journal of Controlled Release 82 (2002) 17-27. (Pubitemid 34775044)
17. S.J. Zhu, M.H. Hong, G.T. Tang, L.L. Qian, J.Y. Lin, Y.Y. Jiang, Y.Y. Pei, Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubic, in: The effects of PEGylation degree and drug conjugation style, Biomaterials 31 (2010) 1360-1371.
18. S.J. Zhu, M.H. Hong, L.H. Zhang, G.T. Tang, Y.Y. Jiang, Y.Y. Pei, PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation, Pharmaceutical Research 27 (2010) 161-174.
19. S.J. Zhu, L.L. Qian, L.H. Zhang, Y.Y. Pei, Y.Y. Jiang, RGD-modified PEG-PAMAM- DOX conjugate: in vitro and in vivo targeting to both tumor neovascular endothelial cells and tumor cells, Advanced Materials (in press).
20. D. Raucher, A. Chilkoti, Enhanced uptake of a thermally responsive polypeptide by tumor cells in response to its hyperthermia-mediated phase transition, Cancer Research 61 (2001) 7163-7170. (Pubitemid 32946510)
21. V. Kansara, D. Paturi, S.H. Luo, R. Gaudana, A.K. Mitra, Folic acid transport via high affinity carrier-mediated system in human retinoblastoma cells, International Journal of Pharmaceutics 355 (2008) 210-219.
22. Y.Y. Jiang, G.T. Tang, L.H. Zhang, S.Y. Kong, S.J. Zhu, Y.Y. Pei, PEGylated PAMAM dendrimers as a potential drug delivery carrier: in vitro and in vivo comparative evaluation of covalently conjugated drug and noncovalent drug inclusion complex, Journal of Drug Targeting 18 (2010) 389-403.
23. M.S. Aguzzi, P. Fortugno, C. Giampietri, G. Ragone, M.C. Capogrossi, A. Facchiano, Intracellular targets of RGDS peptide in melanoma cells, Molecular Cancer 9 (2010) (Article No.: 84).
24. R.D. Arnold, D.E. Mager, J.E. Slack, R.M. Straubinger, Effect of repetitive administration of doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model, Clinical Cancer Research 11 (2005) 8856-8865. (Pubitemid 43005938)
25. C.Y. Zhan, B. Gu, C. Xie, J. Li, Y. Liu, W.Y. Lu, Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel antiglioblastoma effect, Journal of Controlled Release 143 (2010) 136-142.
26. D.A. Gewirtz, A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin, Biochemical Pharmacology 57 (1999) 727-741. (Pubitemid 29094544)
27. X.B. Xiong, Y. Huang, W.L. Lu, X. Zhang, H. Zhang, T. Nagai, Q. Zhang, Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo, Journal of Pharmaceutical Sciences 94 (2005) 1782-1793. (Pubitemid 41360872)
28. A.J. Schraa, R.J. Kok, H.E. Moorlag, E.J. Bos, J.H. Proost, D.K.F. Meijer, L. de Leu, G. Molema, Targeting of RGD-modified proteins to tumor vasculature: a pharmacokinetic and cellular distribution study, International Journal of Cancer 102 (2002) 469-475. (Pubitemid 35316000)
29. R.M. Schiffelers, G.A. Koning, T.L.M. ten Hagen, M. Fens, A.J. Schraa, A. Janssen, R.J. Kok, G. Molema, G. Storm, Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin, Journal of Controlled Release 91 (2003) 115-122. (Pubitemid 37288882)